Glimestar-PM1 Tablet ER

 87.89

Glimestar-PM1 Tablet ER


Category:

Description

MANUFACTURER

Mankind Pharma Ltd

SALT COMPOSITION

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)

INTRODUCTION

Glimestar-PM1 Tablet ER is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar level.

Glimestar-PM1 Tablet ER is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar level.

USES OF GLIMESTAR-PM TABLET ER

  • Type 2 diabetes mellitus

GLIMESTAR-PM TABLET ER SIDE EFFECTS

Common
  • Hypoglycemia (low blood sugar level)
  • Nausea
  • Taste change
  • Diarrhea
  • Stomach pain
  • Headache
  • Edema (swelling)
  • Weight gain
  • Blurred vision
  • Bone fracture
  • Respiratory tract infection

HOW TO USE GLIMESTAR-PM TABLET ER

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimestar-PM1 Tablet ER is to be taken with food.
Glimestar-PM1 Tablet ER may cause stomach upset if taken empty stomach.

HOW GLIMESTAR-PM TABLET ER WORKS

Glimestar-PM1 Tablet ER is a combination of three antidiabetic medicines: Glimepiride, Metformin and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body’s sensitivity to insulin. Pioglitazone is a thiazolidinedione which further increases insulin sensitivity.

GLIMESTAR-PM TABLET ER RELATED WARNINGS

warnings Alcohol
It is unsafe to consume alcohol with Glimestar-PM1 Tablet ER
warnings Pregnancy
Glimestar-PM1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
warnings Lactation
Glimestar-PM1 Tablet ER is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Monitor the breastfed baby’s blood sugar during treatment with Glimestar-PM1 Tablet ER
warnings Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
warnings Kidney
Glimestar-PM1 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glimestar-PM1 Tablet ER may be needed. Please consult your doctor.
Use of Glimestar-PM1 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
warnings Liver
Glimestar-PM1 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glimestar-PM1 Tablet ER may be needed. Please consult your doctor.
Use of Glimestar-PM1 Tablet ER is not recommended in patients with severe liver disease.

Reviews

There are no reviews yet.

Be the first to review “Glimestar-PM1 Tablet ER”

Your email address will not be published. Required fields are marked *